This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Equine Fibroblast Growth Factor (FGF8), N-His
Product Overview
BioVenic's Recombinant Equine Fibroblast Growth Factor (FGF8), N-His is a recombinant protein expressed from E.coli. Its predicted molecular weight is N/A. The purity is>95% (SDS-PAGE).
Specifications
Target Information
Equine fibroblast growth factor 8, androgen induced (FGF8) is a protein that belongs to the fibroblast growth factor family, playing a significant role in various biological processes such as embryonic development, tissue regeneration, and maintaining homeostasis. FGF8 is involved in the regulation of cell proliferation, growth, and migration, and it has been shown to contribute to limb morphogenesis. It also plays a role in the animal models of osteoarthritis, where it is produced by injured synovium and enhances the production of protease and prostaglandin E2 from inflamed synoviocytes, leading to the degradation of the extracellular matrix and exacerbation of osteoarthritis.
Shipping and Storage
This product is shipped with dry ice. It is recommended to aliquot as needed and store at -80°C upon receipt. Reconstituted protein solution can be stored at 4°C for 1 week, at < -80°C for 12 months. Avoid repeated freezing and thawing.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Aliquot the reconstituted solution to minimise freeze-thaw cycles.